AstraZeneca COVID booster shot effective against severe disease, finds UK study
The researchers from the UK Health Security Agency, London, estimated vaccine effectiveness by analysing data on all adults aged…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
AstraZeneca
AstraZeneca says its COVID shot has market potential despite lower demand
AstraZeneca has started earning a modest profit on the vaccine, which was initially sold at-cost. However, the British drugmaker…
Poorer nations shun millions of AstraZeneca COVID-19 vaccine doses
Countries declined to receive nearly 35 million AstraZeneca doses, opting to replace them with vaccines manufactured by Johnson…
Japan cancels a third of contracted Astrazeneca vaccine purchase
The contract allowed the government to cancel a portion of the supply if it was unneeded
ICMR study has shown rise in antibodies post Covaxin booster dose: MoS Health tells RS
International data available on booster doses of AstraZeneca and Covishield suggests a three-to four-fold increase in antibody…
EU approves Evusheld for preventing COVID-19
Evusheld retains neutralising activity against the Omicron BA.2 subvariant
Evusheld recommended for approval in EU for prevention of COVID-19
Recommendation based on phase-III Provent trial showing a significant reduction in the risk of developing symptomatic COVID-19,…
AstraZeneca COVID drug neutralises Omicron sub-variants in lab study
This is the first data looking at the impact of AstraZeneca's Evusheld treatment on "cousins" of the Omicron variant following a…
US FDA declines to approve AstraZeneca treatment for chronic nasal condition
The drugmaker said the US Food and Drug Administration (FDA) had issued a complete response letter following AstraZeneca's…
AstraZeneca and Neurimmune ink $760 million deal for antibody drug
Under the agreement, Alexion would pay Neurimmune an upfront payment of $30 million and it would be eligible for payments of up to…